Vertical Right Axillary Mini-Thoracotomy for Correction of Ventricular Septal Defects and Complete Atrioventricular Septal Defects. by Heinisch, Paul Philipp et al.
Accepted Manuscript
Vertical Right Axillary Mini-Thoracotomy for Correction of Ventricular Septal Defects
and Complete Atrioventricular Septal Defects
Paul Philipp Heinisch, Marc Wildbolz, Maria Julia Beck, Maris Bartkevics, Brigitta
Gahl, Balthasar Eberle, Gabor Erdoes, Hans-Joerg Jenni, Florian Schoenhoff, Jean-
Pierre Pfammatter, Thierry Carrel, Alexander Kadner
PII: S0003-4975(18)30730-6
DOI: 10.1016/j.athoracsur.2018.05.003
Reference: ATS 31650
To appear in: The Annals of Thoracic Surgery
Received Date: 29 December 2017
Revised Date: 28 April 2018
Accepted Date: 3 May 2018
Please cite this article as: Heinisch PP, Wildbolz M, Beck MJ, Bartkevics M, Gahl B, Eberle B, Erdoes
G, Jenni HJ, Schoenhoff F, Pfammatter JP, Carrel T, Kadner A, Vertical Right Axillary Mini-Thoracotomy
for Correction of Ventricular Septal Defects and Complete Atrioventricular Septal Defects, The Annals of
Thoracic Surgery (2018), doi: 10.1016/j.athoracsur.2018.05.003.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Vertical Right Axillary Mini-Thoracotomy for Correction of Ventricular Septal Defects and 
Complete Atrioventricular Septal Defects 
Running Head: Mini thoracotomy for VSD and CAVSD 
 
Paul Philipp Heinisch1, Marc Wildbolz2, Maria Julia Beck1, Maris Bartkevics1, Brigitta Gahl1, Balthasar 
Eberle3, Gabor Erdoes3, Hans-Joerg Jenni1, Florian Schoenhoff1, Jean-Pierre Pfammatter2, Thierry 
Carrel1, Alexander Kadner1 
 
1 Centre for Congenital Heart Disease, Department of Cardiovascular Surgery, Inselspital, University 
Hospital, University Bern, Bern, Switzerland 
2 Centre for Congenital Heart Disease, Department of Cardiology, Inselspital, University Hospital, 
University Bern, Bern, Switzerland 
3 Department of Anaesthesiology and Pain Therapy, Inselspital, University Hospital, University Bern, 
Bern, Switzerland 
 
Key Words: Vertical right axillary mini-thoracotomy, ventricular septal defect, complete atrioventricular 
septal defects 
 
Corresponding author:  
Alexander Kadner, MD 
Centre for Congenital Heart Disease 
Department of Cardiovascular Surgery 
Inselspital, University Hospital Bern 
Freiburgstrasse 18 
CH - 3010 Berne, Switzerland 
Email: alexander.kadner@insel.ch 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Abstract 
Background. Vertical-right-axillary-mini-thoracotomy (VRAMT) is the standard approach for correction 
of atrial septal defect (ASD) and partial atrioventricular septal defects (PAVSD) at our institution. This 
observational single-centre study compares our initial results with the VRAMT approach for the repair 
of ventricular septal defects (VSD) and complete atrioventricular septal defects (CAVSD) in infants and 
children to an approach using standard median sternotomy (MS). 
Methods. Perioperative course of patients undergoing VSD and CAVSD correction through either a 
VRAMT or a MS were analysed retrospectively. The surgical technique for the VRAMT involved a 4-5 
cm vertical incision in the right axillary fold.  
Results. Of 84 patients, 25 patients (VSD, n=15; CAVSD, n=10) underwent correction through a 
VRAMT approach, whereas 59 patients (VSD, n=35; CAVSD, n=24) had repair through MS. VSD and 
CAVSD-groups were comparable with respect to age and weight. No significant differences were 
observed for aortic cross-clamp duration, intensive care unit stay, hospital stay and echocardiographic 
follow-up. There was no need for any conversion from VRAMT to MS in any case. No wound infection 
nor thoracic deformities were observed in both groups.  
Conclusions. VRAMT can be considered as a safe and effective approach for the repair of VSD and 
CAVSD in selected patient groups, and the outcome data appears comparable to those of median 
sternotomy.  
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Evolving surgical techniques and medical care have led to a significant decrease of the mortality and 
complication rate following congenital heart surgery during the past decades. A complete surgical 
repair allows both a normal life expectancy and excellent quality of life in the majority of children. At 
the same time, there is a quest for less invasive and aesthetically superior surgical access [1-3]. 
Median sternotomy (MS) has been the standard surgical approach for heart surgery, providing optimal 
exposure of all cardiac structures and allowing easy accessibility for central arterial and venous 
cannulation and installation of cardio-pulmonary-bypass (CPB). However, median sternotomy is 
invasive and results in a scar that is well visible on the chest of growing children, which can be 
potentially stigmatising and trigger long-lasting psychological distress [4-6].  
Consequently, several alternative surgical approaches have been proposed like right anterolateral 
thoracotomy [7,8], posterolateral thoracotomy [9,10], and partial sternotomy [3,11]. They have however 
been concluded as suboptimal, sometimes because of visibility of the scar, sometimes because of 
long term consequences like thorax deformity or, especially such as the anterolateral-thoracotomy 
when performed in pre-pubescent females, impairment of breast development [12,13].  
The axillar region represents an interesting surgical access to the thoracic cavity due to particular 
anatomical properties: The skin is flexible, muscles are relatively rare and can therefore be spared, it is 
far away from breast tissue in girls, and the resulting scar is hidden under the resting arm [6]. As other 
studies have already examined, the right axillary access has proven sufficiently exposure of the right 
atrium and right heart structures, as needed for instance for ASD, VSD and CAVSD. [4]. Furthermore, 
an eventual scar in the right axilla has shown to be fairly unsuspicious for heart disease, since the 
anatomical correlation to the heart in the right hemi-thorax is not given [6].  
Several groups have already reported their experience with this approach for the correction of atrial-
septal-defect (ASD), ventricular-septal-defect (VSD), and partial-atrioventricular-septal-defects 
(PAVSD) [6,14-18]. Correction of complete-atrioventricular-septal-defects (CAVSD) through a vertical-
right-axillary-mini-thoracotomy (VRAMT) has not yet been described before.  
The objective of this study is to analyse outcomes and surgical results of VRAMT for correction of VSD 
and CAVSD in comparison to repair through a MS. 
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Patients and Methods 
Patient selection and data collection 
An observational retrospective single-centre study was conducted using perioperative clinical patient 
data retrieved from clinical records, surgery and follow-up reports. The study was approved by the 
Cantonal-Ethics-Committee (approval no. 2016-01484). Patients who underwent corrective heart 
surgery by VRAMT for either a perimembranous VSD or a CAVSD (Rastelli type A), starting from 
January 2012 until August 2016 were included and compared to patients who underwent correction via 
MS. All surgical procedures either VRAMT or MS for the correction of VSD or CAVSD were performed 
by the same surgeon (AK). To ensure comparability between study groups, patients with a body 
weight >10 kg were excluded. An observational design was used conforming to the STROBE 
statement [19]. All data was gathered in a standardized database using the Research-Electronic-Data-
Capture (REDCap) system. Patient characteristics, procedural data and outcomes are shown in 
Tables 1-4. 
 
Patient selection for VRAMT 
Since several years, VRAMT has been the standard approach for repair of secundum ASD, sinus 
venosus defect, partial-anomalous-pulmonary-venous-return, partial atrioventricular septal defects, 
permanent pacemaker and ICD-implantation in paediatric patients at our institution. Given the growing 
experience with this cosmetically appealing and less invasive approach, and its comparable results, 
our group extended its use, since 2012, to perimembranous VSD repair. Since 2014 we also used the 
VRAMT approach for elective correction of CAVSD with a Rastelli classification type A [20]. 
 
Statistical analysis 
Variables were presented as numbers with % or as median with interquartile ranges. Differences were 
investigated using Fisher’s exact test for four filed tables, χ2 test for tables with more than four fields 
and Kruskal-Wallis test for continuous variables and were presented with 95% confidence interval (CI). 
All p values and confidence intervals were two sided. All calculations were performed using Stata 12 
(College Station, Texas). 
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Follow up 
The follow-up included ambulatory visits with clinical examination and echocardiography by senior 
paediatric cardiologists at one, three and six months postoperatively, and yearly thereafter. All follow-
up data until 31st of August 2017 were included in the analyses. Follow-up variables are presented as 
numbers with percent or as mean ± standard deviation (SD). For the purpose of this study all 
echocardiographic data at discharge and the most recent follow-up are included.  
 
Definition of major adverse cardiac and cerebrovascular events 
Major adverse cardiac and cerebrovascular events (MACCE) was defined as one of these events: 
sudden cardiac death, fatal or non-fatal myocardial-infarction (MI), arrhythmias needing intervention 
with permanent pacemaker, stroke, or renal failure requiring prolonged dialysis. MI criteria for this 
study were defined according to the 2012 Third Universal Definition of Myocardial Infarction by the 
European Society of Cardiology Guidelines. elevation of cardiac biomarker values >10 x 99th 
percentile URL in patients with normal baseline troponin values. In addition, either (i) new pathological 
Q waves or new LBBB, or (ii) angiographic documented new native coronary artery occlusion, or (iii) 
imaging evidence of new loss of viable myocardium or new regional wall motion abnormality [21].  
 
Surgical technique  
Patients received general anaesthesia after induction with sevoflurane, sufentanil and rocuronium. For 
tracheal intubation, a single-lumen paediatric endotracheal tube was used. Intraoperative monitoring 
consisted of American-Society-of-Anaesthesiologists standard monitoring, invasive arterial blood 
pressure via a left-sided radial artery or left-sided femoral artery catheter, central-venous-pressure via 
a jugular venous catheter, nasopharyngeal temperature, urine output, transesophageal-
echocardiography (TEE) and cerebral-near-infrared-spectroscopy (NIRS). Patients undergoing 
correction of VSD and CAVSD through a VRAMT were placed in a left decubitus position (Figure 1). 
Prior to positioning, the anterior, posterior axillary line and 4th intercostal space was outlined in supine 
position with arms in adduction. Following lateral positioning of the child the arm was elevated to 
expose the axillary region.  
A vertical incision of 4-5 cm parallel to the right anterior axillary fold was performed overlying the 4th or 
5th-intercostal-space. The subcutaneous tissue was generously mobilized. the serratus anterior muscle 
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overlying the 4th-intercostal-space was identified and the lateral border of the pectoral muscle slightly 
mobilized. Care was taken to avoid injury to the long thoracic nerve and artery lying posteriorly on the 
serratus anterior muscle. Thoracotomy was performed at the superior margin of the 5th-rib in the 4th 
intercostal space. A retractor by Fehling Surgical Instruments (V-CUT Titanium MSX-1 for 3-7 kg 
Bodyweight or MSX-2 for 7-15kg Bodyweight) was used for VRAMT. The pericardium was opened 1- 2 
cm anterior to the phrenic nerve (Figure 2 A.). Stay sutures were placed along both the margins of the 
pericardium and fixed to the surrounding drapes to retain the lungs. 
CPB was established following cannulation of the ascending aorta and both vena cava. The inferior-
vena-cava was either cannulated directly or in patients > 5kg a percutaneous-venous-cannula (BIO-
MEDICUS, Medtronic, Pediatric-Venous-Cannulae) was inserted in the Seldinger-technique into the 
femoral vein and a LV-vent (Figure 2.B). CPB was conducted in mild-hypothermia, the aorta was 
cross-clamped directly and antegrade-cardioplegia was administered by using a low-dose (1.5 ml/kg), 
single-shot crystalloid solution (Cardioplexol™) [22]. The surgical repair of VSD and CAVSD through 
VRAMT was performed using standard technique and is shown in Figure 3. Deairing was performed 
via the LV-vent and the aortic root cardioplegia needle and removed after successful de-airing and 
echocardiographic confirmation of good left-ventricular function. During rewarming epicardial 
temporary-pacing-electrodes were placed to the right atrium and ventricle. Following decannulation 
and haemostasis the pericardium was closed except a distal opening of about 1-2 cm for drainage of 
pericardial fluid into the right pleura. A subpleural-paravertebral-catheter was placed covering two 
segments each cranial and caudal to the VRAMT interspace for postoperative pain management at a 
period of 72 hours, using a continuous infusion of bupivacaine 0.125% with adrenaline 5 mcg/ml. Two 
chest drains were inserted, and the chest was closed with absorbable suture material (Figure 4 A.).  
 
Results 
Perioperative Data 
VSD patients 
There were 50 patients included in the VSD group, n= 35 operated through median sternotomy (MS), 
and n= 15 patients through vertical right axillary mini-thoracotomy (VRAMT). Median age was 4.1 (3.5 
- 5.7) months in the MS-VSD group and 4.3 (3.3 - 6.3) months in the VRAMT-VSD group (p= 0.841). 
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While 31% of patients were female in the MS-VSD group, the VRAMT-VSD group held a majority, 
60%, of female patients. Patients were comparable regarding bodyweight (p= 0.525) and height (p= 
0.688). Baseline data and additional diagnosis of VSD patients are shown in Table 1.  
 
CAVSD patients 
From a total of 34 patients with a CAVSD Rastelli type A, 24 were operated through MS and 10 
patients through VRAMT. The median-age was 3.7 (3.1 - 7.8) months in the MS-group and 6.1 (4.5 - 
10.5) months in the VRAMT-group. CAVSD patients were comparable for bodyweight (p= 0.174) and 
height (p= 0.219). Non-cardiac diagnosis included Trisomy 21 for 17 patients in the MS-group and 4 
patients in the VRAMT-group. Table 2 shows the preoperative demographics of CAVSD patients.  
 
Intra- and postoperative Assessment  
None of the patients with VRAMT had to be converted to another surgical access. There were two 
postoperative deaths, one in the MS-VSD-group (Trisomy 18 with severe co-morbidities) and one in 
the MS-CAVSD-group (pulmonary hypertension crisis and resuscitation).  
 
VSD patients 
The intra- and postoperative data of VSD patients is listed in table 3. The median operating duration 
(p= 0.597) and aortic-cross-clamp-times (p= 0.182) were comparable between the groups. 
Cardiopulmonary bypass time was longer in the VRAMT groups (p= 0.015). The median ventilation-
time resulted in 43 (22 - 82) hours for patients in the MS-group and 24 (17 - 47) hours in the VRAMT-
group (p= 0.043).  
 
CAVSD patients 
The operating times for the VRAMT were significantly shorter (p= 0.003), whereas central CPB-time 
(p= 0.597) and aortic-cross-clamp-time (p= 0.241) of the patients in the MS and VRAMT-group were 
comparable. Postoperative rhythms in the MS-group included one persistent AV-Block III° with the 
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indication for a permanent pacemaker. Table 4 shows the intra- and postoperative data of CAVSD 
patients.  
 
Echocardiographic Follow-up 
VSD patients 
For VSD patients the mean follow-up was complete with a time of 8.1 months (±6.9) in the VRAMT-
group and 52.3 months (±25.7) in the MS group. No significant residual defects were found in patients 
of both groups. No patient required a reoperation. At last follow-up, there were four patients with trivial 
residual VSDs, two in the MS-VSD-group, and two in the VRAMT-VSD-group respectively. In clinical 
examination, no wound complications or thoracic deformity has been found during the follow-up.  
 
CAVSD patients 
Mean follow-up time in the CAVSD-group was complete with a mean follow-up time of 8.6 months (± 
10.3) in the VRAMT-group and 52.9 months (± 28.9) in the MS group. No patient required a 
reoperation during the follow-up period. At last follow-up, trivial residual VSDs were found in two 
patients from the MS-CAVSD-group.  
Left AV-valve insufficiency was found in 17 patients (77%) in the MS-CAVSD-group (trivial n=15, mild 
to moderate n=2) vs. seven patients (70%) in the VRAMT-CAVSD-group (Trivial n= 5, mild to 
moderate n=2), respectively. In the MS-CAVSD-group 15 patients (68%) presented with trivial and one 
patient (5%) with mild to moderate right AV-valve insufficiency, while in the VRAMT-CAVSD-group six 
patients (60%) with trivial right AV-valve insufficiency. In clinical examination, no wound complications 
or thoracic deformity has been found during the follow-up.  
 
Comment 
The use of less invasive lateral thoracotomy in paediatric patients for the correction of congenital heart 
defects has been reported as feasible and safe in various publications [4,5,18,23,24]. The vertical right 
axillary mini-thoracotomy aims to provide superior cosmetic results without compromising the surgical 
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outcome when employed for congenital heart defects, such as atrial septal defects (ASD), ventricular 
septal defect (VSD), and partial atrio-ventricular septal defects (PAVSD). 
In our institution, the surgical correction of perimembranous ventricular septal defects through a right-
axillary-mini-thoracotomy was started in 2012. Due to the growing experience and surgical results, and 
the high satisfaction of the children and their parents, as well as cardiologists, we extended this 
approach to the correction of “simple” CAVSD with a Rastelli type A. To our knowledge, there are no 
reports on the application of a VRAMT approach for the correction of CAVSD. 
As far as aortic-cross-clamp-times, cardiopulmonary-bypass-time and operation-time are concerned, 
VRAMT procedures are comparable to standard MS surgery, indicating an adequate exposure and 
access to the anatomical structures. Furthermore, VRAMT procedures can be performed using 
standard instruments for access and the correction itself. These findings confirm previously reported 
advantages and results by other groups [4,18,23-25]. 
As an advantage of our approach patients weighing < 5kg were operated with central arterial and 
venous cannulation avoiding potential peripheral vascular complications. In patients weighing > 5 kg 
peripheral percutaneous-femoral-venous-cannulation was performed. No vascular complications were 
encountered. The use of femoral artery cannulation for CPB has led to vascular complications in other 
studies and should therefore be performed only with limited indication and meticulous technique [4,25].  
The echocardiographic follow-up revealed a moderate AV-valve insufficiency in two patients for the 
MS-CAVSD-group (8%) and also in two patients for the VRAMT-CAVSD-group (20%). Furthermore, 
no wound complications or development of thorax deformities were observed. Long-term follow-up 
revealed comparable surgical results for VRAMT in comparison to MS for VSD patients. There was no 
need for re-operations in the current follow-up period for VSD and CAVSD patients. The long term 
outcome after primary repair of CAVSD remains strongly influenced by the function of the left 
atrioventricular valve, including in particular the risk for reoperation [26]. Regarding reinterventions 
after VRAMT-CAVSD repair, our group would aim towards a re-thoracotomy in these patients. 
However, we have to admit, that the experience is limited to only two cases necessitating reoperation 
due to endocarditis after PAVSD repair and ASD repair. Both patients had an uneventful perioperative 
course and good surgical results.  
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In the current presented study collective there were two deaths in the MS-groups, one in the MS-VSD-
group and one in the MS-CAVSD-group. The patient in the MS-VSD suffered from Trisomy 18 and 
severe neurological and respiratory insufficiency. Following assessment of the situation of the patient, 
an interdisciplinary team advised against corrective cardiac surgery, nevertheless the surgical 
intervention was the explicit wish of the patient’s parents.  
The intraoperative course was uneventful, however the patient developed progressive global 
hemodynamic and respiratory insufficiency starting at postop day 12. Four days later the 
interdisciplinary team together with the parents decided for limited palliative therapy.  
The patient in the MS-CAVSD-group was diagnosed with Trisomy 21. Surgery was performed on an 
elective schedule with uneventful intraoperative course. During the first postoperative day, the patient 
was resuscitated because of a severe pulmonary hypertension crisis. ECMO implantation was 
performed. Unfortunately, the patient died on the 5th postoperative day due to neurological 
complications and multi-organ failure. Overall the rate of MACE revealed no significant difference 
between the MS and VRAMT-groups.  
In conclusion, this study confirms previous reports which described VRAMT as a feasible, efficient and 
safe approach for surgical repair of perimembranous VSD. Cardiopulmonary bypass can be performed 
without peripheral arterial cannulation. Furthermore, this approach can be applied to the correction of 
CAVSD with Rastelli type A. Considering the beneficial aesthetic factor of this less invasive approach 
and at the comparable surgical results in the long-term, VRAMT can be considered as an equal 
surgical approach for a broader range of congenital heart defects. 
 
Study limitations 
We acknowledge some limitations of our study. It was a retrospective observational analysis and 
therefore cause and effect are hard to establish.  
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List of Abbreviations 
 
ASD - atrial septal defect 
BMI - body mass index 
CAVSD - complete atrioventricular septal defects  
CD – chest drains 
CI - confidence interval 
CPB - cardio-pulmonary-bypass 
CL - cardioplegia line 
ICD - implantable cardioverter defibrillator 
LBBB – left bundle branch block 
MACCE - major adverse cardiac and cerebrovascular events 
MI - myocardial infarction 
PAVSD - partial atrioventricular septal defects  
PE - pacing electrodes 
PFO - persistent foramen ovale 
PLSVC - persistent left superior vena cava,  
MS - median sternotomy 
NIRS - cerebral-near-infrared-spectroscopy 
REDCap - research electronic data capture 
SD - standard deviation 
SVC - superior vena cava 
TEE - transoesophageal-echocardiography 
URL – upper reference limit 
VRAMT - vertical-right-axillary-mini-thoracotomy  
VSD - ventricular septal defects  
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Figure Legends 
Figure 1. Placement of patients in a left decubitus position. The marked anterior axillary line and the 4th 
intercostal space serve as a guiding for the axillary incision. 
 
Figure 2. (A) Vertical skin incision over the region of the 4th – 5th ICS with a length of 3 - 5 cm. 
Mobilisation of subcutaneous tissue and sparing of muscles. Visualization of the right atrium (arrow) 
and superior vena cava (SVC). (B) Direct access cannulation with aortic cannulation (Ao), venous 
cannulation of the superior vena cava (SVC) and cardioplegia line (CL). The inferior vena cava was 
cannulated using percutaneous technique. 
 
Figure 3. (A) Surgical field after atriotomy for the correction of a perimembranous ventricular septal 
defect (VSD). (B) Closure of VSD with a xeno-pericardial patch (arrow). 
 
Figure 4. (A) Initial postoperative access site after closed vertical skin incision. Chest drains (CD) in 
the right pleural cavity and placement of atrial/ventricular pacing electrodes (PE). (B) Long-term 
cosmetic result after VSD closure through VRAMT. 
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Table 1. Preoperative Data of VSD Patients. 
Demographics 
VSD-cohort 
 
MS 
 
VRAMT Difference and 95% 
confidence interval p Value 
N = 35 N = 15 
  
Age [months]  4.1 (3.5; 5.7) 4.3 (3.3; 6.3) -0.2 (-2.5; 2.2) 0.841  
Premature Birth (SSW< 37) 6 (17%) 2 (13%) 4% (-19%; 27%)  1.000  
Gender (Female) 11 (31%) 9 (60%) -29% (-58%; 1%) 0.114 
Weight (kilograms) 5.0 (4.4; 6.2)  5.7 (4.3; 6.8) -0.3 (-1.2; 0.5)  0.525  
Height (cm) 61.0 (58.0; 65.0) 60.0 (58.0; 69.0)  -1.1 (-5.2; 3.0) 0.688 
BMI 13.7 (12.8; 14.3) 13.5 (12.2; 15.8) -0.4 (-1.4; 0.7) 0.604 
Body Surface Area [m^2] 0.3 (0.3; 0.3) 0.3 (0.3; 0.3) -0.0 (-0.0; 0.0) 0.539 
  
    
Additional cardiac diagnosis 
    
ASD Type II 17 (49%) 9 (60%) -11% (-43%; 20%) 0.545 
PLSVC 2 (6%) 1 (7%)   -1% (-16%; 14%) 1.000 
PFO 7 (20%) 0 (0%)   20% (-1%;  41%) 0.087 
  
    
Non-cardiac diagnosis 
    
Genetic 12 (34%) 2 (13%) 21% (-7%;  49%) 0.179 
Trisomy 18 1 (3%) 0 (0%) 3% (-6%;  12%) 1.000 
Trisomy 21 9 (26%) 2 (13%)  12% (-14%; 38%)  0.468  
Di George-Syndrome 
(22q11-Syndrom) 
1 (3%) 0 (0%)  3% (-6%;  12%) 1.000 
Neurology 2 (6%) 0 (0%) 6% (-7%;  18%) 0.519 
Metabolic 2 (6%) 1 (4%)  -1% (-16%; 14%) 1.000 
Urogenital 1 (3%) 0 (0%) 3% (-6%; 12%) 1.000 
Visceral 1 (3%) 0 (0%)  3% (-6%;  12%) 1.000 
BMI: body mass index, ASD: atrial septal defect, PLSVC: persistent left superior vena cava, PFO: 
persistent foramen ovale. Variables are presented as numbers with % or as median with interquartile 
ranges. 
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Table 2. Preoperative Data of CAVSD Patients. 
Demographics 
CAVSD-cohort 
MS VRAMT Difference and 95% 
confidence interval p Value N = 24 N = 10 
Demographics 
    
Age [months] 3.7 (3.1; 7.8) 6.1 (4.5; 10.5) 5.7 (-16.8; 28.1) 0.121  
Premature Birth  5 (21%) 0 (0%) 21% (-6%; 48%) 0.291 
Gender (Female) 13 (54%) 5 (50%) 4% (-35%; 43%) 1.000 
Weight (kilograms) 4.9 (4.4; 6.9) 5.8 (4.6; 8.0)  0.6 (-3.6; 4.7) 0.174 
Height (cm) 59.0 (56.0; 65.5) 67.0 (57.8; 68.5) 0.8 (-13.4; 15.0) 0.219 
BMI 14.2 (13.2; 15.4) 14.4 (13.3; 17.1)  -0.6 (-2.2; 0.9) 0.484 
Body Surface Area [m2] 0.3 (0.3; 0.3) 0.3 (0.3; 0.4)  0.0 (-0.1; 0.2) 0.212 
  
    
Additional cardiac diagnosis 
    
PLSVC 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
PFO 2 (8%) 0 (0%) 8% (-10%; 27%) 1.000 
  
    
Non-cardiac diagnosis 
    
Trisomy 21 17 (71%) 4 (40%) 31% (-6%; 68%) 0.130 
Neurology 2 (8%) 1 (10%) -2% (-24%; 21%) 1.000 
Metabolic 1 (4%) 2 (20%) -16% (-37%; 6%) 0.201 
Urogenital 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
Visceral 4 (17%) 0 (0%) 17% (-8%; 41%) 0.296 
 
BMI: body mass index, PLSVC: persistent left superior vena cava, PFO: persistent foramen ovale. 
Variables are presented as numbers with % or as median with interquartile ranges. 
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Table 3. Intra- and postoperative Data of VSD Patients. 
 Intraoperative Data 
MS VRAMT Difference and 95% 
confidence interval p Value N = 35 N = 15 
          
OR-time [min] 155 (140; 180) 155 (130; 180) 3.0 (-17.4; 23.3) 0.597 
CPB-time [min]  63 (56; 77)  77 (63; 90) -17.5 (-28.2; -6.9) 0.015  
Aortic-cross-clamp-time 
[min] 36 (29; 41)  41 (33; 51) -5.0 (-10.8; 0.9) 0.182 
          
Postoperative Data 
MS VRAMT Difference and 95% 
confidence interval p Value N = 35 N = 15 
Postoperative 
        
Fast-Track: Extubation in OR 0 (0%)    1 (7%)  -7% (-15%; 2%)  0.300  
ICU Stay [h]  96.0 (72.0; 166.0)  72.0 (48.0; 164.0) 30.0 (-14.2; 74.3)  0.212  
Ventilation [h]  43.0 (22.0; 82.0) 24.0 (17.0; 47.0) 30.3 (-0.8; 61.4)  0.043  
Hospital Stay [in d] 
 10.0 (8.0; 13.0)   9.0 (8.0; 12.0) 7.4 (-10.4; 25.1)  0.727  
     
Mortality 
    
Mortality  1 (3%) 0 (0%) 3%  (-6%;  12%) 1.000 
OR: operation room, ICU: intensive care unit, CPB: cardio-pulmonary-bypass. Variables are presented 
as numbers with % or as median with interquartile ranges 
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Table 4. Intra- and postoperative Data of CAVSD Patients. 
Intraoperative Data 
MS VRAMT Difference and 95% 
confidence interval p Value N = 24 N = 10 
OR-time [min] 225 (195; 269) 189 (171; 198)  52.8 (20.0; 85.6) 0.003 
CPB-time [min] 106 (84; 144) 106 (93; 119)  8.0 (-13.8; 29.8) 0.597  
Aortic-cross-clamp-time 
[min] 68 (55; 78) 64.0 (48; 72)  8.6 (-2.7; 19.9) 0.241 
  
    
Postoperative Data 
MS VRAMT Difference and 95% 
confidence interval p Value N = 24 N = 10 
ICU 
    
Fast-Track: Extubation in OR 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
ICU Stay [h] 151.5 (92.3; 229.8) 126.0 (112.5; 192.0)  48.3 (-74.9; 171.5) 0.431 
Ventilation [h] 71.5 (31.0; 100.8) 32.5 (23.8; 54.0) 43.4 (-1.3; 88.1) 0.059 
Hospital Stay [in d] 
          14.0 (8.0; 29.0)         12.5 (8.0; 20.0)      6.3 (-6.4; 18.9)    0.681 
 
MACCE 
    
Renal failure 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
Stroke 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
Pacemaker Implantation 1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
 
Mortality 
    
Mortality  1 (4%) 0 (0%) 4% (-9%; 17%) 1.000 
 
    
OR: operation room, ICU: intensive care unit, CPB: cardio-pulmonary-bypass MACCE: major adverse 
cardiac and cerebrovascular events. Variables are presented as numbers with % or as median with 
interquartile ranges. 
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